Ambu Q3 2021 Investor Presentation – Single-Use Endoscopy Results

Ambu presented Q3 2020/21 results highlighting 7% total company growth and record endoscope unit sales of 1.1 million year-to-date. The company is advancing its single-use endoscopy portfolio with 20 new products targeted by 2022/23, including expansion into GI with FDA submissions, while constructing a new high-scale manufacturing facility in Mexico to support accelerated growth.